| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On February 24, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1995N-0304
|
| Ephedrine Alkaloids: Reports of Adverse Events; Availability
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 1999N-4282
|
| Biotechnology in the Year 2000 and Beyond; Public Meetings
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| 1999P-2630
|
| Establish a Daily Value for "added sugars"
|
|
|
|
|
| 2000D-1598
|
| Voluntary Labeling for Bioengineered Foods
|
|
|
|
|
| 2000N-1396
|
| Bioengineered Foods Consumed By Humans or Animals
|
|
|
|
|
| 2000N-1531
|
| Proposal to Debar Bruce I Diamond PhD, Opportunity for Heari
|
|
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior Notice of Imported Food Shipments
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| 2003H-0432
|
| Civil Money Penalty, Korangy Radiology Associates, PA
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2003N-0136
|
| Adoption of FDA Food Code by Local,State,and Tribal Governme
|
|
|
|
|
| 2003N-0169
|
| Dental Amalgam; Request for Information
|
|
|
|
|
| 2003N-0198
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Medicated Feed Mill License
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| 2004N-0046
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Orphan Drugs
|
|
|
|
|
| 2004P-0085
|
| Esmolol Hydrochloride for injection ,2,500 mg/vital in a lyophilized form is suitable for evaluation under an ANDA
|
|
|
|
| | | | | | | | |
|
|
|
|
| 2000N-1396
|
| Bioengineered Foods Consumed By Humans or Animals
|
|
|
|
|
| EMC 11571
|
| J. Coleman
|
| Vol #:
|
| 349
|
|
|
|
|
| 2000N-1531
|
| Proposal to Debar Bruce I Diamond PhD, Opportunity for Heari
|
|
|
|
|
| ANS
1
|
| HFD-7 to Robert Glickman
|
| Vol #:
|
| 1
|
|
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
|
|
| EMC 1218
|
| D. Comeaux
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 1219
|
| L. Russo
|
| Vol #:
|
| 5
|
|
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
|
|
| EMC 147
|
| H. Anderson
|
| Vol #:
|
| 3
|
|
|
|
|
| 2002N-0278
|
| Bioterrorism; Prior Notice of Imported Food Shipments
|
|
|
|
|
| NCR
4
|
| FDA
|
| Vol #:
|
| 22
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| EMC 310
|
| Dr. B. Martini
|
| Vol #:
|
| 6
|
|
|
|
|
| EMC 311
|
| Dr. B. Martini
|
| Vol #:
|
| 6
|
|
|
|
|
| 2003H-0432
|
| Civil Money Penalty, Korangy Radiology Associates, PA
|
|
|
|
|
| LET
3
|
| Korangy Radiology Associates, P.A., et al.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| EMC 135
|
| K.E. Beagles
|
| Vol #:
|
| 3
|
|
|
|
|
| 2003N-0136
|
| Adoption of FDA Food Code by Local,State,and Tribal Governme
|
|
|
|
|
| SS
1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0169
|
| Dental Amalgam; Request for Information
|
|
|
|
|
| EMC
223
|
| Consumers for Dental Choice
|
| Vol #:
|
| 6
|
|
|
|
|
| 2003N-0198
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Medicated Feed Mill License
|
|
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| EMC 46
|
| P. Bonadonna,EMT-P
|
| Vol #:
|
| 9
|
|
|
|
|
| 2004N-0046
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Orphan Drugs
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0085
|
| Esmolol Hydrochloride for
injection 2,500 mg/vital in a lyophilized form is suitable for evaluation
under an ANDA
|
|
